跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
FOSCARNET KABI 24 MG/ML SOLUCION PARA PERFUSION EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
FOSCARNET KABI 24 MG/ML SOLUCION PARA PERFUSION EFG
Approved
STANDARD
FOSCARNET KABI 24 MG/ML SOLUCION PARA PERFUSION EFG
Fresenius Kabi España, S.A.U.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jun 10, 2020
Approval ID
4dd9e44df42c7790
Company
Fresenius Kabi España, S.A.U.
Type
Standard
Approval Details
Approval Id
4dd9e44df42c7790
Drug Cima Aemps Name
FOSCARNET KABI 24 MG/ML SOLUCION PARA PERFUSION EFG
Register Number
85153
Holder Company Name
Fresenius Kabi España, S.A.U.
Marketing Company Name
Fresenius Kabi España, S.A.U.
Authorization Date
2020-06-10
Dosage Form
SOLUCIÓN PARA PERFUSIÓN
Dose
24 mg/ml
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Fresenius Kabi España, S.A.U.
Active Ingredients
FOSCARNET SODIO HEXAHIDRATO
6000 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jun 10, 2020
Approval ID
4dd9e44df42c7790
Type
Standard
Back to CIMA-AEMPS Approvals
